Cargando…

Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Murakami, Naoka, Borges, Thiago J., Yamashita, Michifumi, Riella, Leonardo V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957732/ https://www.ncbi.nlm.nih.gov/pubmed/27478613 http://dx.doi.org/10.1093/ckj/sfw058

Ejemplares similares

Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma
por: Murakami, Naoka, et al.
Publicado: (2016)

Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
por: Escandon, Julia, et al.
Publicado: (2017)

The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
por: Marco, Tucci, et al.
Publicado: (2019)

CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
Publicado: (2019)

Acute interstitial nephritis related to immune checkpoint inhibitors
por: Belliere, Julie, et al.
Publicado: (2016)

Not transplanting kidney donors with acute kidney injury: a missed opportunity?
por: Murakami, Naoka, et al.
Publicado: (2019)

Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
por: Miao, Jing, et al.
Publicado: (2023)

Hyperacute Onset of Immune Checkpoint Inhibitor–Related Acute Interstitial Nephritis
por: Tawhari, Ibrahim, et al.
Publicado: (2020)

Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma
por: Bottlaender, Lea, et al.
Publicado: (2017)

Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis
por: Lin, Jamie S., et al.
Publicado: (2021)

Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
por: Oleas, Diana, et al.
Publicado: (2020)

Differentiating Acute Interstitial Nephritis From Immune Checkpoint Inhibitors From Other Causes
por: Casals, J., et al.
Publicado: (2022)

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
por: Kim, Teresa, et al.
Publicado: (2014)

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
por: Changizzadeh, Pouyan N., et al.
Publicado: (2017)

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma
por: Patel, Viral, et al.
Publicado: (2020)

Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis
por: Qualls, David, et al.
Publicado: (2019)

BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
por: Veppil Muralidharan, Somsundar, et al.
Publicado: (2017)

Pathogenesis of Henoch-Schönlein purpura nephritis
por: Lau, Keith K., et al.
Publicado: (2009)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy
por: Baker, Megan L, et al.
Publicado: (2022)

Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy
por: Pérez-Sáez, María José, et al.
Publicado: (2018)

Acute interstitial nephritis due to proton pump inhibitors
por: Sampathkumar, K., et al.
Publicado: (2013)

Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib—A case report
por: Krelle, Anna, et al.
Publicado: (2021)

ACUTE INTERSTITIAL NEPHRITIS
por: Councilman, W. T.
Publicado: (1898)

Granulomatous interstitial nephritis
por: Shah, Shivani, et al.
Publicado: (2015)

Metrorrhagia in Interstitial Nephritis
por: Cumston, Charles Greene
Publicado: (1905)

Chronic Interstitial Nephritis
por: Gillis, J. A.
Publicado: (1896)

Levetiracetam-induced severe acute granulomatous interstitial nephritis
por: Chau, Katrina, et al.
Publicado: (2012)

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
por: Kawashima, Shun, et al.
Publicado: (2022)

Checkpoint Inhibitors Immunotherapy in Metastatic Melanoma: When to Stop Treatment?
por: De Risi, Ivana, et al.
Publicado: (2022)

Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
por: L’Orphelin, Jean-Matthieu, et al.
Publicado: (2023)

Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016)

Severe Acute Interstitial Nephritis: Response to Therapy With Antithymocyte Globulin
por: Shao, Tiffany, et al.
Publicado: (2016)

Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
por: Eskiocak, Ugur, et al.
Publicado: (2016)

Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report
por: Langan, Ewan A., et al.
Publicado: (2021)

Hyperprogression in Pediatric Melanoma Metastatic to the Breast Treated with a Checkpoint Inhibitor
por: Bernal Vaca, Laura, et al.
Publicado: (2019)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2020)

Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
por: Bol, Kalijn Fredrike, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hhtlf0qcissd0bbh9rvr071nic